| Secondary |
| Chronic Myeloid Leukaemia |
38.5% |
| Renal Cell Carcinoma |
11.5% |
| Depression |
7.7% |
| Metastases To Bone |
7.7% |
| Pain |
7.7% |
| Renal Cancer |
7.7% |
| Drug Use For Unknown Indication |
3.8% |
| Gastritis |
3.8% |
| Product Used For Unknown Indication |
3.8% |
| Renal Cancer Metastatic |
3.8% |
| Renal Cell Carcinoma Stage Unspecified |
3.8% |
|
| Platelet Count Decreased |
31.3% |
| Gastric Cancer |
18.8% |
| Completed Suicide |
12.5% |
| Vomiting |
12.5% |
| Haematuria |
6.3% |
| Haemoptysis |
6.3% |
| Interstitial Lung Disease |
6.3% |
| Neutrophil Count Decreased |
6.3% |
|
| Concomitant |
| Metastatic Renal Cell Carcinoma |
23.3% |
| Chronic Myeloid Leukaemia |
17.5% |
| Renal Cell Carcinoma |
13.8% |
| Metastases To Bone |
10.4% |
| Hypertension |
6.0% |
| Renal Cell Carcinoma Stage Iv |
6.0% |
| Prophylaxis |
5.4% |
| Anaesthesia Procedure |
3.0% |
| Diabetes Mellitus |
2.4% |
| Hepatitis C |
2.0% |
| Renal Cancer |
1.9% |
| Gastritis |
1.3% |
| Hyperuricaemia |
1.1% |
| Cancer Pain |
0.9% |
| Cardiac Failure |
0.9% |
| Drug Use For Unknown Indication |
0.9% |
| Pain |
0.9% |
| Chemotherapy |
0.7% |
| Compression Fracture |
0.7% |
| Cough |
0.7% |
|
| Rash |
17.2% |
| Renal Impairment |
11.1% |
| Electrocardiogram Qt Prolonged |
8.1% |
| Tumour Haemorrhage |
7.1% |
| Neoplasm Malignant |
6.1% |
| Vomiting |
6.1% |
| Platelet Count Decreased |
5.1% |
| Pyrexia |
5.1% |
| Alopecia |
4.0% |
| Parkinsonism |
4.0% |
| White Blood Cell Count Decreased |
4.0% |
| Renal Cell Carcinoma |
3.0% |
| Respiratory Disorder |
3.0% |
| Skin Necrosis |
3.0% |
| Stevens-johnson Syndrome |
3.0% |
| Dyspnoea |
2.0% |
| Hepatic Function Abnormal |
2.0% |
| Jaundice |
2.0% |
| Lymphocyte Count Decreased |
2.0% |
| Meningitis |
2.0% |
|
| Interacting |
| Renal Cell Carcinoma |
100.0% |
|
| Aspartate Aminotransferase Increased |
100.0% |
|
